Mouw K[au] - Search Results

Year	Number of Results
2007	1
2008	1
2009	1
2010	3
2012	2
2013	4
2014	5
2015	2
2016	3
2017	13
2018	19
2019	15
2020	16
2021	18
2022	5

1

DNA Damage and Repair Biomarkers of Immunotherapy Response.

Mouw KW, Goldberg MS, Konstantinopoulos PA, D'Andrea AD. Mouw KW, et al. Cancer Discov. 2017 Jul;7(7):675-693. doi: 10.1158/2159-8290.CD-17-0226. Epub 2017 Jun 19. Cancer Discov. 2017. PMID: 28630051 Free PMC article. Review.

2

CDKN2A Alterations and Response to Immunotherapy in Solid Tumors.

Adib E, Nassar AH, Akl EW, Abou Alaiwi S, Nuzzo PV, Mouhieddine TH, Sonpavde G, Haddad RI, Mouw KW, Giannakis M, Hodi FS, Shukla SA, Gusev A, Braun DA, Choueiri TK, Kwiatkowski DJ. Adib E, et al. Among authors: mouw kw. Clin Cancer Res. 2021 Jul 15;27(14):4025-4035. doi: 10.1158/1078-0432.CCR-21-0575. Epub 2021 Jun 1. Clin Cancer Res. 2021. PMID: 34074656 Free PMC article.

3

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer.

Zhu S, Ma AH, Zhu Z, Adib E, Rao T, Li N, Ni K, Chittepu VCSR, Prabhala R, Garisto Risco J, Kwiatkowski D, Mouw K, Sonpavde G, Cheng F, Pan CX. Zhu S, et al. Among authors: mouw k. J Immunother Cancer. 2021 Nov;9(11):e002917. doi: 10.1136/jitc-2021-002917. J Immunother Cancer. 2021. PMID: 34725212 Free PMC article.

4

ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer.

Rafiei S, Fitzpatrick K, Liu D, Cai MY, Elmarakeby HA, Park J, Ricker C, Kochupurakkal BS, Choudhury AD, Hahn WC, Balk SP, Hwang JH, Van Allen EM, Mouw KW. Rafiei S, et al. Among authors: mouw kw. Cancer Res. 2020 Jun 1;80(11):2094-2100. doi: 10.1158/0008-5472.CAN-19-3126. Epub 2020 Mar 3. Cancer Res. 2020. PMID: 32127357 Free PMC article.

5

A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer.

Polak P, Kim J, Braunstein LZ, Karlic R, Haradhavala NJ, Tiao G, Rosebrock D, Livitz D, Kübler K, Mouw KW, Kamburov A, Maruvka YE, Leshchiner I, Lander ES, Golub TR, Zick A, Orthwein A, Lawrence MS, Batra RN, Caldas C, Haber DA, Laird PW, Shen H, Ellisen LW, D'Andrea AD, Chanock SJ, Foulkes WD, Getz G. Polak P, et al. Among authors: mouw kw. Nat Genet. 2017 Oct;49(10):1476-1486. doi: 10.1038/ng.3934. Epub 2017 Aug 21. Nat Genet. 2017. PMID: 28825726 Free PMC article.

6

Orchestrating serine resolvases.

Rice PA, Mouw KW, Montaño SP, Boocock MR, Rowland SJ, Stark WM. Rice PA, et al. Among authors: mouw kw. Biochem Soc Trans. 2010 Apr;38(2):384-7. doi: 10.1042/BST0380384. Biochem Soc Trans. 2010. PMID: 20298188 Free PMC article. Review.

7

Bladder preservation: Translating discovery for clinical impact in urothelial cancer.

Miyamoto DT, Abbosh PH, West CML, Mouw KW. Miyamoto DT, et al. Among authors: mouw kw. Urol Oncol. 2021 Apr;39(4):201-208. doi: 10.1016/j.urolonc.2020.11.021. Epub 2020 Nov 28. Urol Oncol. 2021. PMID: 33257220 Review.

8

Clinical characterization of radiation-associated muscle-invasive bladder cancer.

Sha ST, Dee EC, Mossanen M, Mahal BA, Zaslowe-Dude C, Royce TJ, Hirsch MS, Sonpavde G, Preston MA, Nguyen PL, Mouw KW, Muralidhar V. Sha ST, et al. Among authors: mouw kw. Urology. 2021 Aug;154:208-214. doi: 10.1016/j.urology.2021.03.033. Epub 2021 Apr 20. Urology. 2021. PMID: 33857569

9

Applying Precision Oncology Principles in Radiation Oncology.

Kamran SC, Mouw KW. Kamran SC, et al. Among authors: mouw kw. JCO Precis Oncol. 2018 May 14;2:PO.18.00034. doi: 10.1200/PO.18.00034. eCollection 2018. JCO Precis Oncol. 2018. PMID: 32914000 Free PMC article. Review.

10

DNA Repair Pathway Alterations in Bladder Cancer.

Mouw KW. Mouw KW. Cancers (Basel). 2017 Mar 27;9(4):28. doi: 10.3390/cancers9040028. Cancers (Basel). 2017. PMID: 28346378 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results